Albert McKee

Title: Albert McKee - Innovator in Hepatitis B Immunization

Introduction

Albert McKee is a notable inventor based in Flemington, NJ (US). He has made significant contributions to the field of immunology, particularly in the development of immunizing agents against hepatitis B virus disease. His innovative approach has led to advancements in medical treatments that benefit public health.

Latest Patents

Albert McKee holds a patent for the "Preparation of a hepatitis B immune globulin and use thereof." This patent describes a method for producing a novel immunizing agent that is anti-HBs gamma globulin, essentially free of fibrinogen, plasminogen, 19 S globulin, and lipids. The immunizing agent has been found effective in immunizing against hepatitis B virus disease. The production method involves the fractionation of human plasma utilizing selective solvents and careful control of pH, temperature, and ionic strength.

Career Highlights

McKee is associated with Ortho Diagnostics, Inc., where he has applied his expertise in immunology to develop effective treatments. His work has been instrumental in advancing the understanding and management of hepatitis B, a significant health concern worldwide.

Collaborations

Albert McKee has collaborated with William Pollack, contributing to the research and development of immunological solutions. Their partnership has fostered innovation in the field, leading to improved health outcomes.

Conclusion

Albert McKee's contributions to the field of immunology, particularly through his patent on hepatitis B immune globulin, highlight his role as an innovator in medical science. His work continues to impact public health positively.